GLP-compliant program covering rodents, non-rodents, and primates will define safety, MTD and safe dose ranges, targeting weight loss and TIIDMNovel Ibogaine formulation development for mental health ...
Phyto-N 28-Day Repeat-Dose Study in Rats and Dogs Shows No Findings of Toxicological Significance at Maximum Feasible Dose, Enabling Advancement to GLP Toxicology Program Jericho, New York, March 18, ...
Silexion Therapeutics (SLXN) announced the successful completion of toxicology studies for SIL204, the Company’s next-generation RNA silencing therapy targeting mutated KRAS oncogenes, ahead of its ...
– SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity or residual agonism observed in non-human primate ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule ...
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced the initiation of a Good Laboratory Practice (GLP) toxicology study to evaluate the ...
The Board on Environmental Studies and Toxicology was formed in February 1986 from the merger of the Board on Toxicology and Environmental Health Hazards (est. 1977) and the Environmental Studies ...
Data from a preclinical chronic toxicology study have torpedoed AbbVie’s psoriasis prospect cedirogant, leading the company to dump the midphase asset and cut off a source of cash for its partner ...
German company MVZ Medizinische Labore Dessau Kassel GmbH (MVZ) has positioned itself as an industry leader in the development of rapid, sensitive means of testing for drugs of abuse using capillary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results